Proud to provide both patients and the NHS with high quality medicines that deliver NHS value and address unmet need.
Lupin Healthcare is a subsidiary of the global pharmaceutical company Lupin Limited, where its heritage lie in generic medicines. Today’s portfolio consists of high quality generics with a focus on anti-retroviral and oral contraceptives. In January 2019 Lupin launched its first medicines in the neuromuscular space.
The entrepreneurial spirit, external focus and pipeline strength transitions Lupin in the UK from standard generics through to a more specialist organisation partnering with the NHS to deliver value.
Our 3 key focus areas:
HIV anti-retrovirals and oral contraceptives are key generic products in the UK with a future focus on more complex generics and biosimilars.
Lupin have launched a medicine for a rare neurological condition. Further developments in neurology are underway.
Strong Respiratory R&D expertise with products filed to deliver a future broad respiratory portfolio.
LUP-CORP-005s DOP: December 2020